Antihypertensive therapy in chronic renal disease: a place for sympathicolytic agents?

Anti-Phospholipase A2 Receptor Antibody Titer Predicts Post-Rituximab Outcome of Membranous Nephropathy.

Journal of the American Society of Nephrology : JASN·2015

Direct reprogramming of human bone marrow stromal cells into functional renal cells using cell-free extracts.

Stem cell reports·2015

Renal progenitors derived from human iPSCs engraft and restore function in a mouse model of acute kidney injury.

Scientific reports·2015

Need for chronic kidney disease prevention programs in disadvantaged populations.

Clinical nephrology·2015

Renal effects of atorvastatin and rosuvastatin in patients with diabetes who have progressive renal disease (PLANET I): a randomised clinical trial.

The lancet. Diabetes & endocrinology·2015

Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies.

Kidney international·2015

Blood Pressure Reactivity and Urinary Abnormalities in Young Athletes.

Journal of hypertension·2026

Continual cuffless blood pressure monitoring in children: agreement and feasibility compared with ambulatory blood pressure monitoring.

Journal of hypertension·2026

Long-term treatment with soluble guanylyl cyclase stimulator BAY41-8543 abolishes malignant hypertension-related mortality and attenuates organ damage: studies in Ren-2 transgenic rats treated with L-NAME.

Journal of hypertension·2026

Sex differences in associations of periodontitis with blood pressure and arterial stiffening: the Hordaland Health Study.

Journal of hypertension·2026

Diagnostic recognition of primary aldosteronism in clinical practice.

Journal of hypertension·2026

Prognostic significance of invasive central and peripheral blood pressures for cardiovascular events and mortality.

Journal of hypertension·2026

[Buprenorphine and pain management: Clinical insights and practical landmarks].

Therapie·2026

Clinical Physiology of SGLT2 Inhibitors in Non-diabetic and Diabetic Individuals.

Handbook of experimental pharmacology·2026

Must RAAS-modifying drugs be withdrawn for the diagnosis of primary aldosteronism?

The Journal of clinical endocrinology and metabolism·2026

Phosphate storm in chronic kidney disease-mineral and bone disorder: practical clinical strategies for vascular calcification control.

Nephron·2026

Combination Treatment of IL-17 Inhibitor and JAK Inhibitor in Psoriatic Arthritis: A Case Report and Scoping Review.

Immunity, inflammation and disease·2026

Intranasal midazolam vs mouth-dissolving clobazam in terminating seizures: A randomized controlled trial.

Epilepsia·2026

Related Experiment Videos

Antihypertensive therapy in chronic renal disease: a place for sympathicolytic agents?

Related Concept Videos

Anti-Phospholipase A2 Receptor Antibody Titer Predicts Post-Rituximab Outcome of Membranous Nephropathy.

Direct reprogramming of human bone marrow stromal cells into functional renal cells using cell-free extracts.

Renal progenitors derived from human iPSCs engraft and restore function in a mouse model of acute kidney injury.

Need for chronic kidney disease prevention programs in disadvantaged populations.

Renal effects of atorvastatin and rosuvastatin in patients with diabetes who have progressive renal disease (PLANET I): a randomised clinical trial.

Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies.

Blood Pressure Reactivity and Urinary Abnormalities in Young Athletes.

Continual cuffless blood pressure monitoring in children: agreement and feasibility compared with ambulatory blood pressure monitoring.

Long-term treatment with soluble guanylyl cyclase stimulator BAY41-8543 abolishes malignant hypertension-related mortality and attenuates organ damage: studies in Ren-2 transgenic rats treated with L-NAME.

Sex differences in associations of periodontitis with blood pressure and arterial stiffening: the Hordaland Health Study.

Diagnostic recognition of primary aldosteronism in clinical practice.

Prognostic significance of invasive central and peripheral blood pressures for cardiovascular events and mortality.

[Buprenorphine and pain management: Clinical insights and practical landmarks].

Clinical Physiology of SGLT2 Inhibitors in Non-diabetic and Diabetic Individuals.

Must RAAS-modifying drugs be withdrawn for the diagnosis of primary aldosteronism?

Phosphate storm in chronic kidney disease-mineral and bone disorder: practical clinical strategies for vascular calcification control.

Combination Treatment of IL-17 Inhibitor and JAK Inhibitor in Psoriatic Arthritis: A Case Report and Scoping Review.

Intranasal midazolam vs mouth-dissolving clobazam in terminating seizures: A randomized controlled trial.

Related Experiment Videos

Antihypertensive therapy in chronic renal disease: a place for sympathicolytic agents?

Related Concept Videos

Related Articles